Carcinoid syndrome MRI: Difference between revisions
Jump to navigation
Jump to search
(→MRI) |
Ahmed Younes (talk | contribs) No edit summary |
||
| (9 intermediate revisions by 4 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Abdominal MRI scan may be | On [[abdominal]] [[MRI]], [[carcinoid tumor]] is characterized by [[nodular]] [[mass]] originating from the [[bowel]] wall or regional uniform [[bowel]] wall [[thickening]] with moderate intense enhancement on [[Gadolinium|postgadolinium]] [[T1 relaxography|T1-weighted]] fat-suppressed images. [[Abdominal]] [[MRI|MRI scan]] may be performed to detect [[metastases]] of [[carcinoid syndrome]] to [[liver]] and [[mesentery]]. | ||
==MRI== | ==MRI== | ||
On abdominal MRI, carcinoid syndrome is characterized by: | On [[abdominal]] [[MRI]], [[carcinoid syndrome]] is characterized by:<ref name="pmid11536403">{{cite journal| author=Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT| title=MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. | journal=J Magn Reson Imaging | year= 2001 | volume= 14 | issue= 3 | pages= 261-9 | pmid=11536403 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11536403 }} </ref> | ||
*Nodular mass originating from the bowel wall or regional uniform bowel wall thickening with moderate intense enhancement on | *Nodular [[mass]] originating from the [[bowel]] wall or regional uniform [[bowel]] wall thickening with moderate intense enhancement on post-[[gadolinium]] [[T1 relaxography|T1-weighted]] fat-suppressed [[images]]. | ||
*Mesenteric metastases presented as nodular masses with [[mesenteric]] stranding. | *[[Mesenteric]] [[metastases]] presented as [[nodular]] [[masses]] with [[mesenteric]] stranding. | ||
*[[Liver]] metastases may show hypointense | *[[Liver]] [[metastases]] may show hypointense pre[[contrast]] [[T1 relaxography|T1]]- and hyperintense T2-weighted images. | ||
*[[Liver]] metastases are commonly hypervascular. | *[[Liver]] [[metastases]] are commonly hypervascular. | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WS}} | |||
{{WH}} | {{WH}} | ||
[[Category: | [[Category:Gastroenterology]] | ||
[[Category: | [[Category:Endocrinology]] | ||
[[Category:Pulmonology]] | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Needs content]] | |||
[[Category:Needs overview]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Surgery]] | ||
Latest revision as of 19:51, 3 May 2019
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome MRI On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome MRI |
|
Risk calculators and risk factors for Carcinoid syndrome MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
On abdominal MRI, carcinoid tumor is characterized by nodular mass originating from the bowel wall or regional uniform bowel wall thickening with moderate intense enhancement on postgadolinium T1-weighted fat-suppressed images. Abdominal MRI scan may be performed to detect metastases of carcinoid syndrome to liver and mesentery.
MRI
On abdominal MRI, carcinoid syndrome is characterized by:[1]
- Nodular mass originating from the bowel wall or regional uniform bowel wall thickening with moderate intense enhancement on post-gadolinium T1-weighted fat-suppressed images.
- Mesenteric metastases presented as nodular masses with mesenteric stranding.
- Liver metastases may show hypointense precontrast T1- and hyperintense T2-weighted images.
- Liver metastases are commonly hypervascular.
References
- ↑ Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT (2001). "MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver". J Magn Reson Imaging. 14 (3): 261–9. PMID 11536403.